2022
Exports
$713MWorld Rnk 3 / 119
Flag Rnk 314 / 1217
2022
PRODUCT COMPLEXITY IN Oxygen Heterocyclic Compounds
1.05Rnk 152 / 1025
2022
Imports
$1.72BWorld Rnk 1 / 196
Flag Rnk 279 / 1216
2022
ECONOMIC COMPLEXITY of United States
1.47Rnk 10 / 133

About

Exports In 2022, United States exported $713M in Oxygen Heterocyclic Compounds, making it the 3rd largest exporter of Oxygen Heterocyclic Compounds in the world. At the same year, Oxygen Heterocyclic Compounds was the 314th most exported product in United States. The main destination of Oxygen Heterocyclic Compounds exports from United States are: Switzerland ($76.9M), China ($63.4M), Netherlands ($57.3M), Mexico ($57.1M), and South Korea ($47.6M).

The fastest growing export markets for Oxygen Heterocyclic Compounds of United States between 2021 and 2022 were China ($23.6M), Netherlands ($15.4M), and France ($11.9M).

Imports In 2022, United States imported $1.72B in Oxygen Heterocyclic Compounds, becoming the 1st largest importer of Oxygen Heterocyclic Compounds in the world. At the same year, Oxygen Heterocyclic Compounds was the 279th most imported product in United States. United States imports Oxygen Heterocyclic Compounds primarily from: China ($607M), Netherlands ($425M), Ireland ($170M), Switzerland ($86.4M), and India ($57.4M).

The fastest growing import markets in Oxygen Heterocyclic Compounds for United States between 2021 and 2022 were Netherlands ($261M), China ($79.9M), and United Kingdom ($14.6M).

COMPANIES In 2023, leading companies such as WALMART INC (476), DOLE FRESH FRUIT COMPANY (302), and HOME DEPOT, U. S. A., INC. (141) were at the forefront of shipping Oxygen Heterocyclic Compounds to the United States.

Latest Trends

February 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (February 2023 - February 2024)$351k(0.75%)
IMPORT GROWTH (February 2023 - February 2024)$-127M(-38.1%)
MAIN EXPORTER (February 2024)Tennessee$11.7M
MAIN DESTINATION (February 2024)Switzerland$5.23M

This section shows Oxygen Heterocyclic Compounds's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Oxygen Heterocyclic Compounds over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$713M
IMPORTS (2022)$1.72B
NET TRADE (2022)-$1.01B

In 2022, United States exported $713M in Oxygen Heterocyclic Compounds. The main destinations of United States exports on Oxygen Heterocyclic Compounds were Switzerland ($76.9M), China ($63.4M), Netherlands ($57.3M), Mexico ($57.1M), and South Korea ($47.6M).

In 2022, United States imported $1.72B in Oxygen Heterocyclic Compounds, mainly from China ($607M), Netherlands ($425M), Ireland ($170M), Switzerland ($86.4M), and India ($57.4M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Oxygen Heterocyclic Compounds EXPORT MARKETS FOR United States WERE (2021 - 2022):
China$23.6M (59.2%)
Netherlands$15.4M (36.9%)
France$11.9M (100%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Oxygen Heterocyclic Compounds BY United States WERE (2021 - 2022):
Germany-$9.82M (-21.1%)
South Korea-$8.85M (-15.7%)
Singapore-$6.7M (-20.2%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, United States's main exporting competitors in Oxygen Heterocyclic Compounds were:
China $4.03B
Germany $1.68B
In 2022, United States's main importing competitors in Oxygen Heterocyclic Compounds were:
India $796M

Explore Visualizations

Trade Value of Oxygen Heterocyclic Compounds by Exporters

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with